Kassberg Thomas Richard

Passage Bio, Inc. · Director

Kassberg Thomas Richard is listed in filings as Director at Passage Bio, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including sale activity. Recent filings connect the profile to Passage Bio, Inc. (PASG) and Ultragenyx Pharmaceutical Inc (RARE). The current snapshot covers public activity from Oct 2, 2024 to May 21, 2026. Reported amounts are shown as $53.5K to $253.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.